Herborium
2014 Sales Grows 79% Over 2013
The
Company’s Margin Increased a Full Point
Fort
Lee, N.J. March 2, 2015 Herborium® Group, Inc. (OTC Pink: HBRM),
www.Herborium.com, a Botanical
Therapeutics®
Company providing unique, all botanical medicines (Botanical
Therapeutics®), announced today its 2014 financial results. The
company filed a full Financial Report with Legal Opinion on OTC, on
Friday February 28th, 2015.
The
Company results for 2014 have significantly surpassed expectations
and indicate a rapid growth, and a strong improvement over 2013.
Herborium
sales in 2014 grew 79% in comparison to 2013 (from $381,000.00 to
$684,000.00). Herborium surpassed the total annual sales for 2013 in
the Third Quarter of 2014.
The
Company’s gross profit increased by $190,000.00 from $236,000.00 in
2013 to $429,000.00 in 2014 what represents 80% growth over 2013.
The
highly significant increase in Herborium’s revenues and gross
profit has been combined with INCREASE IN COMPANY’S MARGIN that
grew from 61.9% in 2013 to 62.9% in 2014.
2014
annual loss from operations was decreased by 43% comparing to 2013.
Herborium’s
lead product, AcnEase®, achieved a milestone of over 10,000 “likes”
on the Facebook in the USA, what represents increase of 35% over
2013. Newly established French Facebook reached over 1000 “likes”
in the first 4 weeks after its opening.
The
overall growth in revenues, gross profit and gross margin achieved by
the Company in 2014, combined with decrease in loss from operations
and further improvement in brand recognition represent pivotal
factors in Herborium’s prospects for continuous and successful
growth in 2015.
Herborium’s
Management plans to use those achievements as a springboard for
expending company’s presence in the US and global markets through
an acquisition and development of additional distribution channels
and new products. We expect the growth and profitability of our
novel, all natural medicines - Botanical
Therapeutics®”
to continue in 2015 “, commented Dr. Agnes P. Olszewski, CEO and
Chairwoman of Herborium Group.
About
Herborium Group, Inc.
Herborium
Group, Inc., a botanical therapeutics® company that develops,
license and markets proprietary, botanical based medicinal products
to consumers and healthcare professionals. The Company business model
focuses on emerging market opportunities spearheaded by the growth of
a new market sector located between high-cost, high-risk, ethical
pharmaceuticals and commoditized classic nutraceuticals
(supplements). The Company uses clinical validation and a proactive
regulatory strategy based on the FDA Guidance for Industry: Botanical
Drug Products (FDA Guidance 2004) to
establish and maintain a differential advantage. Herborium has
secured a pipeline of botanical ingredients based products in the
areas of dermatological needs, wellness and energy, prostate health,
women’s health and selected sexual disorders resulting from
cardiovascular disease, use of anti-depressants, diabetes, surgical
procedures, and other problems. Herborium Group sells its products in
the United States, the United Kingdom, and continental Europe through
a network of distributors, specialty retailers, and e-commerce. For
more information, please visit www.herborium.com, and
www.acnease.com.
Safe
Harbor Statement: This release contains forward-looking statements
with respect to the results of operations and business of Herborium
Group, Inc., which involves risks and uncertainties. The Company's
actual future results could materially differ from those discussed.
The Company intends that such statements about the Company's future
expectations, including future revenues and earnings, and all other
forward looking statements be subject to the "Safe Harbors"
provision of the Private Securities Litigation Reform Act of 1995.
Contact
Information:
Herborium
Group, Inc. Email:
InvestorsRelations@Herborium.com
No comments:
Post a Comment